Newsmeme!
Discover News you didn't know existed
Hepatitis G
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Judge rejects Desai's request
Published July 1, 2009, 2:26 am, Las Vegas Review-Journal
Hang 'em from the Spaghetti Bowl.
Biolex Therapeutics Announces Completion Of Enrollment In SELECT-2 Phase 2b Trial Of Locteron(R) In Chronic Hepatitis C
Published June 30, 2009, 3:09 am, Medical News Today
Biolex Therapeutics, Inc. announced that it has completed patient enrollment in the SELECT-2 Phase 2b trial of its lead product candidate Locteron® for the treatment of chronic hepatitis C.
Paul Donohue: Abnormal tests create big problems
Published June 29, 2009, 10:09 pm, Detroit News
Dear Dr. Donohue: Last year I was rejected for life-insurance coverage due to an elevated CEA (carcinoembryonic antigen) test. The report stated that, regardless of the value, the test should not be interpreted as absolute evidence of the presence or absence of disease. I had several more tests done, all with no evidence of cancer. Now I can't even obtain medical health coverage, and my coverage ...
OctoPlus' Licensee Biolex Completes Patient Enrollment in Phase IIb Study With Locteron
Published June 29, 2009, 8:53 am, Marketwire
LEIDEN, THE NETHERLANDS--(Marketwire - June 29, 2009) - OctoPlus N.V. ("OctoPlus") (Euronext: OCTO) announces today that its licensee Biolex Therapeutics (see separate Biolex press release on www.biolex.com ) has completed patient enrollment in its SELECT-2 Phase IIb clinical study of Locteron®, a controlled release formulation of interferon alpha for the treatment of chronic hepatitis C. ...
OctoPlus' licensee Biolex completes patient enrollment in Phase IIb study with Locteron
Published June 29, 2009, 8:49 am, Marketwire
LEIDEN, NETHERLANDS--(Marketwire - June 29, 2009) - OctoPlus N.V. ("OctoPlus") (Euronext: OCTO) announces today that its licensee Biolex Therapeutics (see separate Biolex press release on www.biolex.com ) has completed patient enrollment in its SELECT-2 Phase IIb clinical study of Locteron®, a controlled release formulation of interferon alpha for the treatment of chronic hepatitis C. OctoPlus ...
Biolex Therapeutics Announces Completion of Enrollment in SELECT-2 Phase 2b Trial of Locteron(R) in Chronic Hepatitis C
Published June 29, 2009, 6:54 am, Marketwire
PITTSBORO, NC--(Marketwire - June 29, 2009) - Biolex Therapeutics, Inc. announced today that it has completed patient enrollment in the SELECT-2 Phase 2b trial of its lead product candidate Locteron® for the treatment of chronic hepatitis C. Locteron, controlled-release interferon alpha 2b, is designed to improve patient care by providing a more convenient once-every-two week dosing schedule and ...
Sinovac Receives Revised Approvals for Panflu
Published June 29, 2009, 5:00 am, PR Newswire via Yahoo! Finance
Sinovac Biotech Ltd. , a leading developer and provider of vaccines in China, announced today that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration , based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |